Not Signed In - MabThera First-line Treatment Helps Patients With Indolent Lymphoma Live Longer
Sat, 16 Dec 2006 01:00 PM EST
... Roche has announced exciting results from a pivotal phase III study that has followed the outcome of patients with indolent non-Hodgkin's lymphoma (NHL) treated with MabThera over four years ago. [click link for full article] ...
Related Topics
- Non-Hodgkin's Lymphoma
- Hodgkin's Lymphoma
- Lymphoma
- Ardeparin Sodium Injection--No longer available
- Beclomethasone Oral Inhalation
- CAM
- Lymphoma, Burkitt's
- Burkitt's Lymphoma
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Live to Eat or Eat to Live
- Polio Vaccine, Live
- Pioglitazone
- Hodgkin's Lymphoma, Adult
- Adult Hodgkin's Lymphoma
- Adult Non-Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma, Adult
- Caregivers
- Treatment
email this page
print this page
bookmark this page
feedback on this page
